F4, a collagen XIX-derived peptide, inhibits tumor angiogenesis through αvβ3 and α5β1 integrin interaction - Archive ouverte HAL Access content directly
Journal Articles Cell Adhesion and Migration Year : 2021

F4, a collagen XIX-derived peptide, inhibits tumor angiogenesis through αvβ3 and α5β1 integrin interaction

(1) , (1) , (1) , (1) , (2) , (1) , (1) , (1) , (1) , (1) ,
1
2

Abstract

We previously demonstrated that F4 peptide (CNPEDCLYPVSHAHQR) from collagen XIX was able to inhibit melanoma cell migrationin vitro and cancer progression in a mouse melanoma model. The aim of the present work was to study the anti-angiogenic properties of F4 peptide. We demonstrated that F4 peptide inhibited VEGF-induced pseudo-tube formation on Matrigel by endothelial cells and endothelial sprouting in a rat aortic ring assay. By affinity chromatography, we identified αvβ3 and α5β1 integrins as potential receptors for F4 peptide on endothelial cell surface. Using solid phase assays, we proved the direct interaction between F4 and both integrins. Taken together, our results demonstrate that F4 peptide is a potent antitumor agent inhibiting both angiogenesis and tumor cell migration.
Fichier principal
Vignette du fichier
F4, a collagen XIX-derived peptide, inhibits tumor angiogenesis through αvβ3.pdf (1.22 Mo) Télécharger le fichier
Origin : Publisher files allowed on an open archive

Dates and versions

hal-03373617 , version 1 (11-10-2021)

Identifiers

Cite

Jean-Baptiste Oudart, Matthieu Villemin, Bertrand Brassart, Christèle Sellier, Christine Terryn, et al.. F4, a collagen XIX-derived peptide, inhibits tumor angiogenesis through αvβ3 and α5β1 integrin interaction. Cell Adhesion and Migration, 2021, 15 (1), pp.215-223. ⟨10.1080/19336918.2021.1951425⟩. ⟨hal-03373617⟩

Collections

CNRS URCA MEDYC
13 View
22 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More